IL6 and COVID-19: Compared with severe SARS and MERS, characteristic clinical and pathological features of severe COVID-19 include milder thrombocytopenia, higher IL-6 levels, and more frequencies of extrapulmonary manifestations and diffuse microvascular thrombosis with NETosis [211,212,213].